4568.T in “America Imports the World's Drug Prices”
Daiichi Sankyo Company, Limited
Daiichi Sankyo's antibody-drug conjugate franchise, led by Enhertu, depends on premium global oncology pricing that reference policies could compress.
4568.T impact map — “America Imports the World's Drug Prices”
How this story travels from the headline to 4568.T’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading 4568.T impact map…
Price history, marked with story events
Oct 20, 2025 – Oct 19, 2026 · 243 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
America Imports the World's Drug Prices
US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
BEAR side — Daiichi Sankyo's antibody-drug conjugate franchise, led by Enhertu, depends on premium global oncology pricing that reference policies could compress.
Read the full America Imports the World's Drug Prices storyBull side
1 story- The Patent Cliff Sparks a Biotech Land Grab
4568.T in “The Patent Cliff Sparks a Biotech Land Grab”
FadingExposure: not rated yetLarge drugmakers facing revenue holes must buy scarce pipelines, turning clinical validation into strategic currency.
Daiichi Sankyo's antibody-drug conjugate platform has become a prized source of next-generation oncology products and partnership economics.
Bear side
1 story- Viewing
4568.T in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Daiichi Sankyo's antibody-drug conjugate franchise, led by Enhertu, depends on premium global oncology pricing that reference policies could compress.